SCHEMBL999239

SCHEMBL999239

CC(C)(CN1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(F)cc2)C1)[C@H](N)C=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 13/20 0.58
CYP3A4 P08684 1/20 0.44
TGFBR1 P36897 4/20 0.38
CSNK1D P48730 1/20 0.32
CSNK1E P49674 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32
TUBB2A Q13885 1/20 0.32
TUBB8 Q3ZCM7 1/20 0.32
TUBA3E Q6PEY2 1/20 0.32
TUBA1A Q71U36 1/20 0.32
TUBA1C Q9BQE3 1/20 0.32
TUBB6 Q9BUF5 1/20 0.32
TUBB2B Q9BVA1 1/20 0.32
TUBB1 Q9H4B7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL997932 0.91 KCNH2 (0.63) KCNH2CYP3A4TGFBR1CSNK1DCSNK1E
SCHEMBL1051396 0.80 KCNH2 (0.60) KCNH2CYP3A4KDM4EUSP2ALDH1A1
SCHEMBL1000957 0.78 KCNH2 (0.57) KCNH2CYP3A4TGFBR1KDM4EUSP2
SCHEMBL997446 0.78 KCNH2 (0.53) KCNH2CYP3A4TGFBR1CSNK1DCSNK1E
SCHEMBL17626234 0.78 KCNH2 (0.55) KCNH2CYP3A4TGFBR1ALDH1A1
SCHEMBL998632 0.77 KCNH2 (0.62) KCNH2CYP3A4GAA
SCHEMBL2070086 0.76 KCNH2 (0.67) KCNH2CYP3A4KDM4EALDH1A1GAA
SCHEMBL997844 0.76 KCNH2 (0.50) KCNH2CYP3A4KDM4EUSP2ALDH1A1
SCHEMBL997860 0.76 KCNH2 (0.58) KCNH2CYP3A4TGFBR1TUBB4ATUBB
SCHEMBL997952 0.75 KCNH2 (0.63) KCNH2CYP3A4TGFBR1CSNK1DCSNK1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451814-A2 FUSED IMIDAZOLES AND COMPOSITIONS COMPRISING THEM FOR THE TREATMENT OF PARASITIC DISEASES, SUCH AS E.G. MALARIA IRM LLC (BM) 2012-05-16 EP disclosed
WO-2011006143-A2 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES IRM LLC (BM) 2011-01-13 WO disclosed